Phase II trial of vindesine in malignant pleural mesothelioma.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014751:Vindesine / Q000009:adverse effects / Q000627:therapeutic use*
D014751:Vindesine